Examining the association between social cognition and functioning in individuals at ultra-high risk for psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 1, 2017, Pages 83-92

  Cotter, Jack ^a   Bartholomeusz, Cali ^b,c   Papas, Alicia ^b,c   Allott, Kelly ^b,c   Nelson, Barnaby ^b,c   Yung, Alison R ^a   Thompson, Andrew ^d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Functioning; prodrome; psychosis; social cognition; theory of mind; ultra high risk

Indexed keywords

ADULT; ARTICLE; ATTRIBUTIONAL BIAS; AUSTRALIA; CLINICAL ARTICLE; COGNITION ASSESSMENT; CORRELATION ANALYSIS; DEMOGRAPHY; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS ASSESSMENT; GLOBAL FUNCTIONING ROLE SCALE; GLOBAL FUNCTIONING SOCIAL SCALE; HIGH RISK PATIENT; HUMAN; MALE; MULTIPLE REGRESSION; NEGATIVE SYNDROME; PERCEPTION; PSYCHOSIS; RECOGNITION; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; SOCIAL COGNITION; SOCIAL INTERACTION; STRESS; TASK PERFORMANCE; THEORY OF MIND; CONTROL; FACIAL EXPRESSION; PSYCHOLOGY; RISK; YOUNG ADULT;

ADULT; FACIAL EXPRESSION; FEMALE; HUMANS; INTERNAL-EXTERNAL CONTROL; MALE; PSYCHOTIC DISORDERS; RISK; SOCIAL PERCEPTION; THEORY OF MIND; YOUNG ADULT;

EID: 85008682013     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867415622691     Document Type: Article

References (56)

1. Addington J, Cornblatt BA, Cadenhead KS, et al. (2011) At clinical high risk for psychosis: Outcome for nonconverters. American Journal of Psychiatry 168: 800-805.
2. Addington J, Piskulic D, Perkins D, et al. (2012) Affect recognition in people at clinical high risk of psychosis. Schizophrenia Research 140: 87-92.
3. Amminger GP, Allott K, Schlögelhofer M, et al. (2013) Affect recognition and functioning in putatively prodromal individuals. Schizophrenia Research 147: 404-405.
4. Andreasen NC, (1984) Scale for the Assessment of Negative Symptoms. Iowa City, IA: University of Iowa Press.
5. Barbato M, Liu L, Cadenhead KS, et al. (2015) Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort. Schizophrenia Research 2: 133-139.
6. Barbato M, Liu L, Penn DL, et al. (2013) Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis. Schizophrenia Research 150: 542-546.
7. Bartholomeusz CF, Ganella EP, Labuschagne I, et al. (2015) Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia. Schizophrenia Research 168: 614-627.
8. Bechi M, Bosia M, Spangaro M, et al. (2015) Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: Neuropsychological and psychopathological influences on theory of mind improvement. Psychological Medicine 45: 3147-3157.
9. Brissos S, Molodynski A, Dias VV, et al. (2011) The importance of measuring psychosocial functioning in schizophrenia. Annals of General Psychiatry 10: 18.
10. Cacciotti-Saija C, Langdon R, Ward PB, et al. (2015) A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis. Schizophrenia Bulletin 41: 483-493.
11. Carrión RE, Goldberg TE, McLaughlin D, et al. (2011) Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. American Journal of Psychiatry 168: 806-813.
12. Corcoran R, Cahill C, Frith CD, (1997) The appreciation of visual jokes in people with schizophrenia: A study of 'mentalizing' ability. Schizophrenia Research 24: 319-327.
13. Corcoran R, Mercer G, Frith CD, (1995) Schizophrenia, symptomatology and social inference: Investigating 'theory of mind' in people with schizophrenia. Schizophrenia Research 17: 5-13.
14. Cornblatt BA, Auther AM, Niendam T, et al. (2007) Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophrenia Bulletin 33: 688-702.
15. Corrigan PW, Addis IB, (1995) The effects of cognitive complexity on a social sequencing task in schizophrenia. Schizophrenia Research 16: 137-144.
16. Cotter J, Drake RJ, Bucci S, et al. (2014) What drives poor functioning in the at-risk mental state? A systematic review. Schizophrenia Research 159: 267-277.
17. Fett AK, Viechtbauer W, Dominguez MD, et al. (2011) The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis. Neuroscience and Biobehavioral Reviews 35: 573-588.
18. Fioravanti M, Bianchi V, Cinti ME, (2012) Cognitive deficits in schizophrenia: An updated meta analysis of the scientific evidence. BMC Psychiatry 12: 64.
19. Glenthøj LB, Fagerlund B, Randers L, et al. (2015) The FOCUS trial: Cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: Study protocol for a randomised controlled trial. Trials 16: 25.
20. Gold JM, Carpenter C, Randolph C, et al. (1997) Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry 54: 159-165.
21. Goldman HH, Skodol AE, Lave TR, (1992) Revising axis V for DSM-IV: A review of measures of social functioning. American Journal of Psychiatry 149: 1148-1156.
22. Green MF, Bearden CE, Cannon TD, et al. (2012) Social cognition in schizophrenia, part 1: Performance across phase of illness. Schizophrenia Bulletin 38: 854-864.
23. Green MF, Penn DL, Bentall R, et al. (2008) Social cognition in schizophrenia: An NIMH workshop on definitions, assessment, and research opportunities. Schizophrenia Bulletin 34: 1211-1220.
24. Guastella AJ, Ward PB, Hickie IB, et al. (2015) A single dose of oxytocin nasal spray improves higher-order social cognition in schizophrenia. Schizophrenia Research 168: 628-633.
25. Kurtz MM, Richardson CL, (2012) Social cognitive training for schizophrenia: A meta-analytic investigation of controlled research. Schizophrenia Bulletin 38: 1092-1104.
26. Lee TY, Hong SB, Shin NY, et al. (2015) Social cognitive functioning in prodromal psychosis: A meta-analysis. Schizophrenia Research 164: 28-34.
27. Lin A, Wood SJ, Yung AR, (2013) Measuring psychosocial outcome is good. Current Opinion in Psychiatry 26: 138-143.
28. Lin A, Wood SJ, Nelson B, et al. (2011) Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis. Schizophrenia Research 132: 1-7.
29. Lovibond SH, Lovibond PF, (1995) Manual for the Depression Anxiety Stress Scales. Sydney, NSW, Australia: Psychology Foundation.
30. Meyer EC, Carrión RE, Cornblatt BA, et al. (2014) The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin 40: 1452-1461.
31. Meyer JD, Salovey P, Caruso DR, (2002) Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT): User's Manual. Toronto, ON, Canada: Multi-Health Systems Publishers.
32. Miller TJ, McGlashan TH, Rosen JL, et al. (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity. American Journal of Psychiatry 159: 863-865.
33. Nowicki S, Carton J, (1993) The measurement of emotional intensity from facial expressions. Journal of Social Psychology 133: 749-750.
34. Nowicki S, Duke MP, (1974) A locus of control scale for noncollege as well as college adults. Journal of Personality Assessment 38: 136-137.
35. Nowicki S, Duke MP, (1994) Individual differences in the nonverbal communication of affect: The diagnostic analysis of nonverbal accuracy scale. Journal of Nonverbal Behavior 18: 9-35.
36. Nuechterlein KH, Green MF, Kern RS, et al. (2008) The MATRICS consensus cognitive Battery, part 1: Test selection, reliability, and validity. American Journal of Psychiatry 165: 203-213.
37. Overall JE, Gorham DR, (1962) The brief psychiatric rating scale. Psychological Reports 10: 799-812.
38. Pinkham AE, Penn DL, Green MF, et al. (2014) The social cognition psychometric evaluation study: Results of the expert survey and RAND panel. Schizophrenia Bulletin 40: 813-823.
39. Pinkham AE, Penn DL, Green MF, et al. (2015) Social cognition psychometric evaluation: Results of the initial psychometric study. Schizophrenia Bulletin. Epub ahead of print 4. DOI: 10.1093/schbul/sbv056.
40. Reitan RM, (1955) The relation of the trail making test to organic brain damage. Journal of Consulting Psychology 19: 393-394.
41. Salokangas RK, Nieman DH, Heinimaa M, et al. (2013) Psychosocial outcome in patients at clinical high risk of psychosis: A prospective follow-up. Social Psychiatry and Psychiatric Epidemiology 48: 303-311.
42. Savla GN, Vella L, Armstrong CC, et al. (2013) Deficits in domains of social cognition in schizophrenia: A meta-analysis of the empirical evidence. Schizophrenia Bulletin 39: 979-992.
43. Stanford AD, Messinger J, Malaspina D, et al. (2011) Theory of Mind in patients at clinical high risk for psychosis. Schizophrenia Research 131: 11-17.
44. Strassnig MT, Raykov T, O'Gorman C, et al. (2015) Determinants of different aspects of everyday outcome in schizophrenia: The roles of negative symptoms, cognition, and functional capacity. Schizophrenia Research 165: 76-82.
45. Thompson A, Papas A, Bartholomeusz C, et al. (2012) Social cognition in clinical 'at risk' for psychosis and first episode psychosis populations. Schizophrenia Research 141: 204-209.
46. Thompson A, Papas A, Bartholomeusz C, et al. (2013) Externalized attributional bias in the Ultra High Risk (UHR) for psychosis population. Psychiatry Research 206: 200-205.
47. Velthorst E, Nieman DH, Linszen D, et al. (2010) Disability in people clinically at high risk of psychosis. British Journal of Psychiatry 197: 278-284.
48. Wechsler D, (1997) Wechsler Memory Scale-Administration and Scoring Manual. San Antonio, TX: Harcourt Assessment.
49. Wechsler D, (1999) Wechsler Abbreviated Scale of Intelligence (WASI). New York: The Psychological Corporation.
50. Woolley JD, Chuang B, Lam O, et al. (2014) Oxytocin administration enhances controlled social cognition in patients with schizophrenia. Psychoneuroendocrinology 47: 116-125.
51. Yung AR, Cotter J, Wood SJ, et al. (2015) Childhood maltreatment and transition to psychotic disorder independently predict long term functioning in young people at ultra high risk for psychosis. Psychological Medicine 45: 3453-3465.
52. Yung AR, McGorry PD, McFarlane CA, et al. (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin 22: 283-303.
53. Yung AR, Nelson B, Thompson A, et al. (2010) The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid? Schizophrenia Research 120: 1-6.
54. Yung AR, Phillips LJ, McGorry PD, et al. (1998) Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry Supplement 172: 14-20.
55. Yung AR, Phillips LJ, Yuen HP, et al. (2004) Risk factors for psychosis in an ultra high-risk group: Psychopathology and clinical features. Schizophrenia Research 67: 131-142.
56. Yung AR, Yuen HP, McGorry PD, et al. (2005) Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Australian and New Zealand Journal of Psychiatry 39: 964-971.